Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

Extrahepatic dissemination is infrequent in HCC patients treated with TACE. TBS is easily calculable and helps in identifying patients at higher risk of metastasis development.

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2026-01-14
DOI
https://doi.org/10.1111/apt.70534
Citations
3
Primary Topic
Hepatocellular Carcinoma Treatment and Prognosis
Type
article
Field-Weighted Citation Impact
70.15
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

Donatella Magalotti, F. Marra, C. Saitta, Gianluca Svegliati‐Baroni et al.
3 citations
Alimentary Pharmacology & Therapeutics
Hepatocellular Carcinoma Treatment and Prognosis
70.15
article

Tumour Burden Score as a Predictor of Extrahepatic Progression After Transarterial Chemoembolization for Hepatocellular Carcinoma: An Observational Multicenter Study

Donatella Magalotti, F. Marra, C. Saitta, Gianluca Svegliati‐Baroni, Franco Trevisani, E. Giannini, Giacomo Zaccherini, Giorgia Ghittoni, Rodolfo Sacco, Mariacristina Di Marco, G. Vidili, Sara Boninsegna, Francesca Romana Ponziani, Filippo Pelizzaro, Bernardo Stefanini, Sara Grasselli, Giuseppe Cabibbo, Laura Bucci, Gerardo Pio Nardone, Vittorio Simeon, the ITA.LI.CA study group, Elisa Pinto, Andrea Martini, Andrea Mega, Maurizia Rossana Brunetto, Alessandro Vitale, Filomena Morisco, Angelo Sangiovanni, Francesco Azzaroli, Francesco Giuseppe Foschi, Martina Gambato, Francesco Paolo Russo
article en
3 citations

Abstract

Extrahepatic dissemination is infrequent in HCC patients treated with TACE. TBS is easily calculable and helps in identifying patients at higher risk of metastasis development.

Alimentary Pharmacology & Therapeutics
Università Cattolica del Sacro Cuore (IT), University of Messina (IT), University of Verona (IT), Marche Polytechnic University (IT), University of Padua (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Ospedale di Bolzano (IT), Azienda Ospedaliera Universitaria Integrata Verona (IT), Azienda Ospedaliera Bolognini Seriate (IT), Ospedale Sacro Cuore Don Calabria (IT), Azienda Ospedaliero Universitaria di Sassari (IT), Department of Health (ES), Azienda USL di Bologna (IT), Ospedale per gli Infermi (IT), University of Campania "Luigi Vanvitelli" (IT), Italian Association for Cancer Research (IT), Ospedale di Belcolle (IT), Prefeitura Municipal de Campos dos Goytacazes (BR), Ospedale di Parma (IT), Ospedale Policlinico San Martino (IT), Azienda Ospedale - Università Padova (IT), Azienda Ospedaliera Universitaria Pisana (IT), University of Florence (IT), University of Naples Federico II (IT), University of Genoa (IT), University of Bologna (IT)
Openalex Percentile: Top 0%
Hepatocellular Carcinoma Treatment and Prognosis
70.15
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.